| Christopher Lovell, DPM | |
|
2409 Main St, Bridgeport, CT 06606-5324 | |
| (203) 334-6955 | |
| Not Available |
| Full Name | Christopher Lovell |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 11 Years |
| Location | 2409 Main St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205285582 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 006790 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northern Westchester Hospital | Mount kisco, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Optum Medical Care Pc | 9931013240 | 997 |
News Archive
The BiO Assay, a 3D Bioprinting technology being promoted around the world by the joint venture of Rainbow Coral Corp. (OTCBB: RBCC) and Nano3D Biosciences (n3D), has been awarded a research grant from the Center for Advancement of Science in Space (CASIS)—the sole manager of the International Space Station U.S. National Laboratory.
Amoxicillin is a broad spectrum penicillin, and in the UK is one of the most frequently used antibiotics. It is commonly used either on its own or, where there are particular concerns about resistance, in combination as Co-amoxiclav (as Amoxicillin-clavulanic acid) which extends its anti-bacterial spectrum.
The largest-ever independent, laboratory-based evaluation of rapid diagnostic tests (RDTs) for malaria has shown that some tests on the market perform exceptionally well in tropical temperatures and can detect even low parasite densities in blood samples, while other tests can detect parasites only at high densities.
For individuals with agonizing pain, it is a cruel blow when the gold-standard medication actually causes more pain. Adults and children whose pain gets worse when treated with morphine may be closer to a solution, based on research published in the January 6 on-line edition of Nature Neuroscience.
Medical device pioneer Stentys announced today that the first patient has been enrolled into the ‘APPOSITION II' clinical study—a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in AMI patients. The primary endpoint of the ‘APPOSITION II' study is stent strut apposition at day three post-procedure via extremely high-resolution OCT (optical coherence tomography) imaging.
› Verified 6 days ago
| Provider Name | Optum Medical Care Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1982643003 PECOS PAC ID: 9931013240 Enrollment ID: O20031119000321 |
News Archive
The BiO Assay, a 3D Bioprinting technology being promoted around the world by the joint venture of Rainbow Coral Corp. (OTCBB: RBCC) and Nano3D Biosciences (n3D), has been awarded a research grant from the Center for Advancement of Science in Space (CASIS)—the sole manager of the International Space Station U.S. National Laboratory.
Amoxicillin is a broad spectrum penicillin, and in the UK is one of the most frequently used antibiotics. It is commonly used either on its own or, where there are particular concerns about resistance, in combination as Co-amoxiclav (as Amoxicillin-clavulanic acid) which extends its anti-bacterial spectrum.
The largest-ever independent, laboratory-based evaluation of rapid diagnostic tests (RDTs) for malaria has shown that some tests on the market perform exceptionally well in tropical temperatures and can detect even low parasite densities in blood samples, while other tests can detect parasites only at high densities.
For individuals with agonizing pain, it is a cruel blow when the gold-standard medication actually causes more pain. Adults and children whose pain gets worse when treated with morphine may be closer to a solution, based on research published in the January 6 on-line edition of Nature Neuroscience.
Medical device pioneer Stentys announced today that the first patient has been enrolled into the ‘APPOSITION II' clinical study—a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in AMI patients. The primary endpoint of the ‘APPOSITION II' study is stent strut apposition at day three post-procedure via extremely high-resolution OCT (optical coherence tomography) imaging.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Lovell, DPM 319 E 91st St, Apt 17, New York, NY 10128-5348 Ph: (715) 212-8414 | Christopher Lovell, DPM 2409 Main St, Bridgeport, CT 06606-5324 Ph: (203) 334-6955 |
News Archive
The BiO Assay, a 3D Bioprinting technology being promoted around the world by the joint venture of Rainbow Coral Corp. (OTCBB: RBCC) and Nano3D Biosciences (n3D), has been awarded a research grant from the Center for Advancement of Science in Space (CASIS)—the sole manager of the International Space Station U.S. National Laboratory.
Amoxicillin is a broad spectrum penicillin, and in the UK is one of the most frequently used antibiotics. It is commonly used either on its own or, where there are particular concerns about resistance, in combination as Co-amoxiclav (as Amoxicillin-clavulanic acid) which extends its anti-bacterial spectrum.
The largest-ever independent, laboratory-based evaluation of rapid diagnostic tests (RDTs) for malaria has shown that some tests on the market perform exceptionally well in tropical temperatures and can detect even low parasite densities in blood samples, while other tests can detect parasites only at high densities.
For individuals with agonizing pain, it is a cruel blow when the gold-standard medication actually causes more pain. Adults and children whose pain gets worse when treated with morphine may be closer to a solution, based on research published in the January 6 on-line edition of Nature Neuroscience.
Medical device pioneer Stentys announced today that the first patient has been enrolled into the ‘APPOSITION II' clinical study—a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in AMI patients. The primary endpoint of the ‘APPOSITION II' study is stent strut apposition at day three post-procedure via extremely high-resolution OCT (optical coherence tomography) imaging.
› Verified 6 days ago
Howard W Harinstein Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4695 Main St, Suite 15, Bridgeport, CT 06606 Phone: 203-334-6878 Fax: 203-373-1372 | |
Dr. Tina Marie Chieco-schwartz, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 2320 Main St, Bridgeport, CT 06606 Phone: 203-366-4506 Fax: 203-384-2908 | |
Dr. Robert D. Schwartz, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 2320 Main St, Bridgeport, CT 06606 Phone: 203-366-4506 Fax: 203-384-2908 | |
St Vincents Multispecialty Group Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2409 Main St, Bridgeport, CT 06606 Phone: 203-334-6955 Fax: 203-334-2851 | |
Primed, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4699 Main St, Suite 211, Bridgeport, CT 06606 Phone: 203-374-3464 Fax: 203-374-1020 | |
Family Foot & Ankle Specialists Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 2409 Main St, Bridgeport, CT 06606 Phone: 203-334-6955 Fax: 203-334-2851 |